Sonoma Pharmaceuticals In...

NASDAQ: SNOA · Real-Time Price · USD
5.32
0.05 (0.95%)
At close: Aug 15, 2025, 3:59 PM
5.20
-2.26%
After-hours: Aug 15, 2025, 07:58 PM EDT

Sonoma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-3.46M -4.83M -5.15M -5.09M -3.95M
Depreciation & Amortization
138K 176K 125K 186K 227K
Stock-Based Compensation
224K 516K 669K 382K 371K
Other Working Capital
2.01M 2.02M -1.11M 1.42M -363K
Other Non-Cash Items
174K 161K 106K -2.03M 4K
Deferred Income Tax
357K -109K -37K -829K -1.41M
Change in Working Capital
2.48M 1.69M -1.86M 3.13M 1.38M
Operating Cash Flow
-88K -2.4M -6.15M -4.25M -3.38M
Capital Expenditures
-80K -17K -269K -137K -179K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 15K 11K 38K 567K
Investing Cash Flow
-80K -2K -258K -99K 388K
Debt Repayment
-404K -481K -120K -467K 1.02M
Common Stock Repurchased
-1K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
356K 373K -259K 93K n/a
Financial Cash Flow
3.03M 1.68M 2.49M 7.4M 3.31M
Net Cash Flow
2.25M -692K -3.58M 3.18M 529K
Free Cash Flow
-168K -2.42M -6.42M -4.38M -3.56M